What is Selank?
Understanding a synthetic tuftsin-derived peptide investigated in neurobiology, GABAergic signalling and immune regulation.
Selank is a synthetic heptapeptide derived from tuftsin, a naturally occurring immune-related peptide fragment. Its amino-acid sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro. Researchers have investigated Selank in relation to anxiety-associated behaviour, neurotransmitter signalling, cognition, stress responses and immune regulation. Much of the evidence comes from animal, laboratory and relatively small clinical studies, so its mechanisms and wider clinical relevance remain under investigation.
Quick Answer
Selank is a synthetic seven-amino-acid peptide modelled on the naturally occurring peptide tuftsin. It is principally studied for its effects on GABA-related neurotransmission, stress and anxiety-associated behaviour, cognition, neurotrophic signalling and immune regulation.
Although some human studies have reported anxiety-related findings, the overall evidence base remains limited and is not equivalent to large, internationally replicated clinical trials.
Table of Contents
- What is Selank?
- Where does Selank come from?
- How does Selank work?
- What is GABAergic signalling?
- Why is Selank being researched?
- Current areas of scientific research
- Selank and Semax: what is the difference?
- Frequently Asked Questions
- References
What is Selank?
Selank is a synthetic peptide consisting of seven amino acids:
Threonine–Lysine–Proline–Arginine–Proline–Glycine–Proline
Its abbreviated sequence is:
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Selank was designed from a short sequence related to tuftsin, an endogenous peptide associated with immune-cell activity. Three additional amino acids—Pro-Gly-Pro—were incorporated to improve metabolic stability and extend biological activity.
Researchers have examined Selank in relation to:
- GABAergic neurotransmission
- Anxiety-associated behaviour
- Stress responses
- Learning and memory
- Neurotrophic signalling
- Gene expression
- Cytokine regulation
- Neuroimmune communication
Experimental findings suggest Selank may affect several biological systems rather than acting through one single receptor or pathway.
Where Does Selank Come From?
Selank was developed from a peptide sequence associated with tuftsin.
Tuftsin is a naturally occurring tetrapeptide with the sequence:
Thr-Lys-Pro-Arg
It is produced from part of the heavy chain of immunoglobulin G and has been investigated for its involvement in immune-cell function.
Selank retains this four-amino-acid sequence and adds:
Pro-Gly-Pro
The resulting seven-amino-acid structure was designed to retain biological activity while improving peptide stability.
How Does Selank Work?
Selank does not appear to have one fully established mechanism.
Research has explored several possible pathways.
GABAergic signalling
Laboratory studies suggest Selank can influence the GABAergic system, which is one of the brain’s major inhibitory signalling networks.
Research has reported changes in GABA-receptor binding and alterations in the expression of genes involved in GABA-associated neurotransmission. Selank has therefore been investigated as a possible allosteric modulator of GABA-related signalling rather than as a conventional direct GABA-receptor agonist.
Gene expression
Cell-based research found that Selank altered the expression of genes involved in neurotransmission. Some of these changes showed similarities to those observed following exposure to GABA, supporting a possible connection between Selank and GABAergic regulation.
Neurotrophic signalling
Animal research has investigated Selank’s effect on brain-derived neurotrophic factor, commonly called BDNF.
One rat study reported changes in hippocampal BDNF expression following intranasal administration. BDNF is involved in neuronal maintenance, synaptic plasticity and learning-related biology, although animal findings cannot automatically be assumed to apply to humans.
Immune and cytokine signalling
Because Selank is derived from a tuftsin-related sequence, it has also been investigated for immunomodulatory effects.
A small human study reported changes in the balance of certain cytokines among participants with anxiety-asthenic disorders, suggesting possible interactions between nervous-system and immune signalling.
What is GABAergic Signalling?
GABA stands for gamma-aminobutyric acid.
It is the principal inhibitory neurotransmitter in the mammalian central nervous system. GABAergic signalling helps regulate neuronal excitability by reducing excessive electrical activity between nerve cells.
This system is involved in research concerning:
- Anxiety and stress responses
- Sleep and arousal
- Muscle control
- Emotional regulation
- Learning and memory
- Neural-network stability
Selank is of interest because experimental studies suggest it may modify GABA-receptor binding and GABA-related gene expression without acting identically to traditional benzodiazepine compounds.
Why is Selank Being Researched?
Selank has attracted scientific interest because it combines a neuroactive research profile with a structure derived from an immune-associated peptide.
Researchers have investigated it in relation to:
- Anxiety-associated behaviour
- Stress adaptation
- GABAergic neurotransmission
- Cognitive performance
- Memory and learning
- BDNF regulation
- Cytokine signalling
- Neuroimmune interactions
- Gene-expression changes
- Interactions with established anxiolytic compounds
Small clinical studies have compared Selank with conventional anti-anxiety medication and reported improvements on psychometric measures. However, these studies involved limited participant numbers and should be interpreted cautiously until replicated in larger, independently conducted trials.
Current Areas of Scientific Research
Current and historical Selank research includes:
Neurotransmitter biology
Studies have examined interactions involving GABA receptors and genes associated with neurotransmission.
Anxiety and stress models
Animal and small human studies have evaluated Selank in anxiety-related behavioural and clinical settings.
Cognition and memory
Preclinical experiments have explored learning, recognition memory and cognitive disruption under stress or substance-withdrawal conditions.
Neurotrophic factors
Research has assessed whether Selank influences BDNF expression in brain regions associated with memory and emotional processing.
Immune signalling
Human research has examined changes in cytokine balance and possible neuroimmune effects.
Pharmacological interactions
Experimental studies have investigated how Selank interacts with compounds such as diazepam and whether combined exposure produces distinct effects.
The overall evidence base remains modest, geographically concentrated and heavily dependent on preclinical research.
Selank and Semax: What is the Difference?
Selank and Semax are separate synthetic peptides.
Selank is derived from a tuftsin-related sequence and is principally investigated in relation to:
- GABAergic signalling
- Anxiety-associated behaviour
- Stress responses
- Immune regulation
Semax is derived from a fragment of adrenocorticotropic hormone and is more commonly investigated in relation to:
- Neuroprotection
- Cognitive biology
- Neurotrophic factors
- Cerebral-ischaemia research
- Learning and memory
Although both are often grouped together as neuroactive peptides, they have different structures, origins and research profiles.
We will cover Semax fully in the final core Research Library article.
Frequently Asked Questions
Is Selank naturally occurring?
No.
Selank is synthetic, although its structure is based partly on the naturally occurring peptide tuftsin.
How many amino acids does Selank contain?
Selank contains seven amino acids, making it a heptapeptide.
Its sequence is:
Thr-Lys-Pro-Arg-Pro-Gly-Pro
What is tuftsin?
Tuftsin is a naturally occurring peptide fragment associated with immune function.
Selank contains the tuftsin-related sequence Thr-Lys-Pro-Arg with an additional Pro-Gly-Pro sequence intended to improve stability.
Does Selank bind directly to GABA receptors?
Its exact molecular interaction has not been fully established.
Experimental findings suggest it may modify GABA-receptor binding and regulate genes involved in GABAergic neurotransmission, potentially through allosteric mechanisms.
Is Selank a benzodiazepine?
No.
Selank is a peptide and is structurally unrelated to benzodiazepines. Researchers have compared and combined it with diazepam in experimental studies, but the compounds act differently.
Does Selank affect BDNF?
Animal research has reported changes in hippocampal BDNF expression following Selank administration. This remains a preclinical finding and does not establish the same effect in humans.
Has Selank been studied in humans?
Yes.
Several relatively small human studies have investigated Selank in participants with anxiety-related conditions. These studies reported potentially favourable findings, but larger and more independently replicated trials are required.
Is Selank approved as a medicine in the United Kingdom?
Selank is not a licensed UK medicine. Research products should not be treated as equivalent to approved pharmaceutical preparations.
Is Selank the same as Semax?
No.
They are distinct peptides with different amino-acid sequences, biological origins and principal research applications.
References
- The Molecular Aspects of Heptapeptide Selank Biological Activity — Vyunova TV, et al.
- Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission — Volkova AA, et al.
- Intranasal Administration of the Peptide Selank Regulates BDNF Expression in the Rat Hippocampus In Vivo — Inozemtseva LS, et al.
- Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank in the Therapy of Generalized Anxiety Disorders and Neurasthenia — Zozulia AA, et al.